Prior to my cath procedure I was in a lot of pain due to the blockage in my heart. After having 20+ heart caths I knew that this one would be high risk. My previous cardiologists had warned that they weren’t interested in taking that sort of risk and recommended I just live with it, but I knew I couldn’t fully function unless the blockage was opened up. Dr Farhan Ali of Heart Center of North Texas had spoken of a new device, the Impella 2.5, that could help with the procedure and told me that he would give it a try. After my Protected PCI procedure, I felt a significant amount of relief.
I think it is important for high risk heart failure patients to understand the options that are available to them. For me, it was Impella and as a result, my wife and I now enjoy a routine life on our farm in Godley, Texas, enjoying the daily chores of rural life together.
I would encourage those living with severe coronary artery disease to talk to their cardiologists and find out whether receiving a Protected PCI with the Impella 2.5 is the right treatment option for them.
This blog post was written by Justin Redman, Impella 2.5 patient
The Impella 2.5 system is a temporary (<6 hours) ventricular support device indicated for use during high risk percutaneous coronary interventions (PCI) performed in elective or urgent, hemodynamically stable patients with severe coronary artery disease and depressed left ventricular ejection fraction, when a heart team, including a cardiac surgeon, has determined high risk PCI is the appropriate therapeutic option. Use of the Impella 2.5 in these patients may prevent hemodynamic instability which can result from repeat episodes of reversible myocardial ischemia that occur during planned temporary coronary occlusions and may reduce peri- and post-procedural adverse events.
Protected PCI and use of the Impella 2.5 is not right for every patient. Patients may not be able to be treated with Impella if they have certain pre-existing conditions, which a cardiologist can determine, such as: severe narrowing of the heart valve, severe peripheral artery disease, clots in blood vessels, or a replacement heart valve or certain heart valve deficiencies. Additionally, use of Impella has been associated with risks, including, but not limited to valvular and vascular injury, bleeding, and limb ischemia in certain patients. Learn more about the Impella devices’ approved indications for use, as well as important safety and risk information at www.protectedpci.com/indications-use-safety-information/.